Top Ten most popular articles on Pharmafile.com this week
July 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, healthcare, pharma, pharmaceutical, top 10
It’s Friday, and it’s been a week characterised by a range of promising research results, particularly into HIV and Duchenne …
Nine in 10 people unaware they have hepatitis
July 28, 2017Medical Communications, Research and Development Gilead, biotech, drugs, hepatitis, hepatitis C, pharma, pharmaceutical
The WHO has released a report on the state of hepatitis prevention and treatment to mark World Hepatitis Day, with …
EMA reveals new clinical trial guidelines to reduce patient risk
July 28, 2017Medical Communications, Research and Development EMA, biotech, clinical trials, drugs, pharma, pharmaceutical
The EMA has announced its intention to introduce revised guidelines concerning the use of medicines in first in-human clinical trials …
US scientists carry out first editing of human embryos
July 28, 2017Medical Communications, Research and Development biotech, crispr, drugs, gene editing, gene-editing, pharma, pharmaceutical
In what will be regarded as a watershed moment, scientists working at Oregon Health and Science University have used CRISPR …
GSK heads down digital path creating specific role for incomer
July 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical
GSK has created a whole new role to push the company to strengthen its digital, data and analytics strategy, with …
Department of Health appoints Teva and Sanofi veteran as commercial head
July 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, Sanofi, Teva, biotech, drugs, government, healthcare, pharma, pharmaceuticals
The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …
AZ attempts to clear dust of Mystic trial with $8.5 billion MSD deal
July 27, 2017Medical Communications, Sales and Marketing AstraZeneca, MSD, Merck, biotech, drugs, immunotherapy, mystic, pharma, pharmaceutical
It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …
New research reveals genetic mutations in smoking-related cancers
July 27, 2017Research and Development Cancer, biotech, drugs, health, pharma, pharmaceuticals
Researchers at the Wake Forest School of Medicine in the US have made a big discovery which could help explain …
Essentra packaging facility co-funded by Welsh Government to close
July 27, 2017Manufacturing and Production Essentra, Wales, Welsh Government, biotech, drugs, packaging, pharma, pharmaceutical
Essentra, a manufacturer of packaging for the pharmaceutical and retail industry, has revealed that it is undergoing a consultation process …
AZ’s ‘blockbuster’ lung cancer drug fails, Q2 revenue falls
July 27, 2017Research and Development, Sales and Marketing AstraZeneca, biotech, drugs, healthcare, pharma, pharmaceutical
The long-awaited results for AstraZeneca’s Mystic trial have been revealed and, in a shocking setback for the company, it was …
Study contradicts widely held belief on length of antibiotics use
July 27, 2017Medical Communications, Research and Development Antibiotics, antibiotic resistance, biotech, drugs, pharma, pharmaceutical
If you’ve ever taken a course of antibiotics then you will be familiar with the piece of advice that is …
GSK chief reassured over ‘pragmatic’ Brexit approach
July 26, 2017Medical Communications Emma Walmsley, GSK, biotech, drugs, pharma, pharmaceutical
Amongst other announcements at its second quarter statement, GSK’s CEO, Emma Walmsley, gave a hint towards the British-based company’s desires …
Sanofi Pasteur Korea appoint new General Manager
July 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …
Breakthrough gene therapy shows promise in Duchenne muscular dystrophy
July 26, 2017Research and Development DMD, Duchenne Muscular Dystrophy, University of London, University of Nantes, biotech, drugs, pharma, pharmaceutical
New research, led by teams from AFM-Telethon laboratory in Nantes and the University of London, have developed a gene therapy …
Roche antibody becomes first of its kind authorised for blood cancer
July 26, 2017Research and Development, Sales and Marketing CDF, Cancer, NICE, drugs, lymphoma, pharma, pharmaceutical Roche
NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy …
Janssen single tablet regimen shows Phase 3 success in HIV
July 26, 2017Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals
The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …
Celgene agrees one of the largest settlements for false claims on record
July 26, 2017Research and Development, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical, thalomid
It has been announced that Celgene has agreed to settle a case after a whistle-blower launched a lawsuit against the …
Further evidence of NHS recruitment crisis as vacancies skyrocket
July 25, 2017Medical Communications, Research and Development NHS, biotech, drugs, midwifery, nursing, pharma, pharmaceutical
Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as …
MSD’s Keytruda hits rare snag, floundering in confirmatory trial
July 25, 2017Manufacturing and Production, Sales and Marketing MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical
Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science …
FDA Chief plans regulatory overhaul to tackle US opioid crisis
July 25, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, biotech, drugs, healthcare, opioid, pharma, pharmaceutical
The US faces an ongoing crisis in opioid dependency, and FDA Commissioner Scott Gottlieb is prepared to employ unusual tactics …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
